vimarsana.com
Home
Live Updates
Brii Biosciences Provides Corporate Update and Reports Full Year 2021 Financial Results : vimarsana.com
Brii Biosciences Provides Corporate Update and Reports Full Year 2021 Financial Results : vimarsana.com
Brii Biosciences Provides Corporate Update and Reports Full Year 2021 Financial Results
/PRNewswire/ -- Brii Biosciences Limited ("Brii Bio", "we" or the "Company", stock code: 2137.HK) a multi-national company developing innovative therapies for...
Related Keywords
China ,
Beijing ,
Hong Kong ,
Shenzhen ,
Guangdong ,
Moldova ,
Ukraine ,
Zhi Hong ,
Brii Bio ,
Vir Biotechnology Inc ,
Infections Program ,
National Health Commission Of China ,
Brii Biosciences Limited Bio ,
Owners Of The Company ,
Vaccines Inc ,
Therapeutics Ltd Beijing Co ,
Cure Program ,
Merck Co Inc ,
China National Medical Products Administration ,
Hong Kong Stock Exchange ,
Brii Biosciences ,
Us Securities Exchange Commission On ,
Tsinghua University ,
China Center ,
Treatment Guidelines ,
Brii Biosciences Limited ,
Greater China ,
Recent Pipeline Highlights ,
Functional Cure ,
Pacific Association ,
Investigational New Drug Application ,
Drug Evaluation ,
Annual Report ,
Exchange Commission ,
Monoclonal Antibody ,
National Health Commission ,
Use Authorization ,
Qualified Infectious Disease Product ,
Non Tuberculosis Mycobacteria ,
Fast Track ,
Nervous System Disease ,
Main Board ,
Stock Exchange ,
Hong Kong Stock Connect ,
Investor Relations ,
Vir Biotechnology ,
Enhanced Stabilization Chemistry Plus ,
Third People ,
Major Depressive Disorder ,
Extensively Drug Resistant ,
Gram Negative Infections ,
Consolidated Statements ,
Biosciences Limited ,